The effect of population structure on the emergence of drug resistance during influenza pandemics

Journal of the Royal Society Interface

Volumn 4, Issue 16, 2007, Pages 893-906

  Débarre, Florence ^a   Bonhoeffer, Sebastian ^a   Regoes, Roland R ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Drug resistance; Influenza; Metapopulation

Indexed keywords

ARTICLE; DRUG RESISTANCE; HUMAN; INFLUENZA; MATHEMATICAL MODEL; PANDEMIC; POPULATION RESEARCH; STOCHASTIC MODEL;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; MODELS, STATISTICAL; OSELTAMIVIR; POPULATION DYNAMICS; TIME FACTORS;

AVES;

EID: 34948841926     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2007.1126     Document Type: Article

References (34)

1. Anderson, R. M. & May, R. M. 1991 Infectious diseases of humans. Oxford, UK: Oxford University Press.
2. Bright, R., Shay, D., Shu, B., Cox, N. & Klimov, A. 2006 Adamantane resistance among influenza a viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295, 891-894. (doi:10.1001/jama.295.8. joc60020)
3. Castillo-Chavez, C., Feng, Z. & Huang, W. 2002 On the computation R0 and its role on global stability. In Mathematical approaches for emerging and reemerging infectious diseases: an introduction (eds C. Castillo-Chavez, P. van den Driessche, D. Kirschner & A.-A. Yakubu), pp. 229-250. Reading, MA: Springer.
4. de Jong, M. D. et al. 2005 Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353, 2667-2672. (doi:10.1056/ NEJMoa054512)
5. Diekmann, O., Heesterbeek, J. & Metz, J. 1990 On the definition and the computation of the basic reproduction ratio R0 in models for infectious-diseases in heterogeneous populations. J. Math. Biol. 28, 365-382. (doi:10.1007/ BF00178324)
6. Doherty, P. C., Turner, S. J., Webby, R. G. & Thomas, P. G. 2006 Influenza and the challenge for immunology. Nat. Immunol. 7, 449-455. (doi:10.1038/ni1343)
7. Ferguson, N., Mallett, S., Jackson, H., Roberts, N. & Ward, P. 2003 A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals. J. Antimicrob. Chemother. 51, 977-990. (doi:10.1093/jac/dkg136)
8. Ferguson, N., Cummings, D., Cauchemez, S., Fraser, C., Riley, S., Meeyai, A., Iamsirithaworn, S. & Burke, D. 2005 Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437, 209-214. (doi:10.1038/ nature04017)
9. Ferguson, N. M., Cummings, D. A. T., Fraser, C., Cajka, J. C., Cooley, P. C. & Burke, D. S. 2006 Strategies for mitigating an influenza pandemic. Nature advanced online publication. (doi:10.1038/nature04795)
10. Germann, T. C., Kadau, K., Longini, I. M. & Macken, C. A. 2006 Mitigation strategies for pandemic influenza in the United States. Proc. Natl Acad. Sci. USA 103, 5935-5940. (doi:10.1073/pnas.0601266103)
11. Gillespie, D. 1976 General method for numerically simulating stochastic time evolution of coupled chemical-reactions. J. Comput. Phys. 22, 403-434. (doi:10.1016/0021-9991 (76)90041-3)
12. Grenfell, B. & Harwood, J. 1997 (Meta)population dynamics of infectious diseases. Trends Ecol. Evol. 12, 395-399. (doi:10.1016/S0169-5347(97)01174-9)
13. Gubareva, L. V., Kaiser, L., Matrosovich, M. N., Soo-Hoo, Y. & Hayden, F. G. 2001 Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J. Infect. Dis. 183, 523-531. (doi:10.1086/318537)
14. Heffernan, J., Smith, R. & Wahl, L. 2005 Perspectives on the basic reproductive ratio. J. R. Soc. Interface 2, 281-293. (doi:10.1098/rsif.2005.0042)
15. Herlocher, M. L., Carr, J., Ives, J., Elias, S., Truscon, R., Roberts, N. & Monto, A. S. 2002 Influenza virus carrying an r292k mutation in the neuraminidase gene is not transmitted in ferrets. Antivir. Res. 54, 99-111. (doi:10. 1016/S0166-3542(01)00214-5)
16. Herlocher, M. L., Truscon, R., Elias, S., Yen, H. L., Roberts, N. A., Ohmit, S. E. & Monto, A. S. 2004 Influenza viruses resistant to the antiviral drug oseltamivir: trans mission studies in ferrets. J. Infect. Dis. 190, 1627-1630. (doi:10. 1086/424572)
17. Hess, G. 1996 Disease in metapopulation models: implications for conservation. Ecology 77, 1617-1632. (doi:10.2307/ 2265556)
18. Hess, G., Randolph, S., Arneberg, P., Chemini, C., Furlanello, C., Harwood, J., Roberts, M. Swinton, J. 2002 The ecology of wildlife diseases, pp. 102-118. Oxford, UK: Oxford University Press.
19. Heymann, D. L. 2006 Resistance to anti-infective drugs and the threat to public health. Cell 124, 671-675. (doi:10. 1016/j.cell.2006.02. 009)
20. Hufnagel, L., Brockmann, D. & Geisel, T. 2004 Forecast and control of epidemics in a globalized world. Proc. Natl Acad. Sci. USA 101, 15 124-15 129. (doi:10.1073/pnas. 0308344101)
21. Kermack, W. O. & McKendrick, A. G. 1927 A contribution to the mathematical theory of epidemics. Proc. R. Soc. A 115, 700-721. (doi:10.1098/rspa.1927.0118)
22. Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F., Sugaya, N. & Kawaoka, Y. 2004 Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364, 759-765. (doi:10.1016/S0140-6736(04)16934-1)
23. Lipsitch, M., Cohen, T., Murray, M. & Levin, B. R. 2007 Antiviral resistance and the control of pandemic influenza. PLoS Med. 4, e15. (doi:10.1371/journal.pmed.0040015)
24. Longini, I., Nizam, A., Xu, S., Ungchusak, K., Hanshaoworakul, W., Cummings, D. & Halloran, M. 2005 Containing pandemic influenza at the source. Science 309, 1083-1087. (doi:10.1126/science.1115717)
25. Mills, C. E., Robins, J. M. & Lipsitch, M. 2004 Transmissibility of 1918 pandemic influenza. Nature 432, 904-906. (doi:10.1038/ nature03063)
26. Moscona, A. 2005 Dec Oseltamivir resistance - disabling our influenza defenses. N. Engl. J. Med. 353, 2633-2636. (doi:10.1056/ NEJMp058291)
27. R Development Core Team, 2005. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. See http://www. R-project.org.
28. Regoes, R. & Bonhoeffer, S. 2006 Emergence of drug-resistant influenza virus: population dynamical considerations. Science 312, 389-391. (doi:10.1126/science.H22947)
29. Setzer, R. W. 2005 Odesolve: solvers for ordinary differential equations. R package version 0.5-13.
30. Smith, D. J. 2003 Applications of bioinformatics and computational biology to influenza surveillance and vaccine strain selection. Vaccine 21, 1758-1761. (doi:10. 1016/S0264-410X(03)00068-9)
31. Stilianakis, N. I., Perelson, A. S. & Hayden, F. G. 1998 Emergence of drug resistance during an influenza epidemic: insights from a mathematical model. J. Infect. Dis. 177, 863-873.
32. Stiver, G. 2003 The treatment of influenza with antiviral drugs. CMAJ 168, 49-57.
33. Webby, R. & Webster, R. 2003 Are we ready for pandemic influenza? Science 302, 1519-1522. (doi:10.1126/science. 1090350)
34. Yen, H. L., Herlocher, L. M., Hoffmann, E., Matrosovich, M. N., Monto, A. S., Webster, R. G. & Govorkova, E. A. 2005 Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob. Agents Chemother. 49, 4075-4084. (doi:10. 1128/AAC.49.10.4075-4084.2005)